<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Etelcalcetide</title><link>https://peptidescanner.com/peptides/etelcalcetide/</link><description>Versioned, source-linked PeptideScanner evidence objects for Etelcalcetide. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/etelcalcetide.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT01134549</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01134549-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01134549-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01134549-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-04-14. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01134562</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01134562-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01134562-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01134562-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-01-02. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01254565</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01254565-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01254565-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01254565-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-04-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01414114</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01414114-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01414114-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01414114-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-04-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01785849</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01785849-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01785849-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01785849-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-08-26. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01785875</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01785875-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01785875-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01785875-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-04-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01788046</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01788046-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01788046-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01788046-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-08-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01896232</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01896232-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01896232-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01896232-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-07-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01932970</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01932970-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01932970-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01932970-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-10-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02102204</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02102204-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02102204-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct02102204-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-11-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02833857</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02833857-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02833857-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct02833857-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-07-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03283098</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03283098-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03283098-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03283098-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-02-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03299244</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03299244-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03299244-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03299244-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-04-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03633708</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03633708-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03633708-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03633708-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-02-27. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03795558</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03795558-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03795558-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03795558-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-03-23. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03960437</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03960437-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03960437-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03960437-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-09-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03969329</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03969329-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03969329-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03969329-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA208325</title><link>https://peptidescanner.com/stories/fda-drugs-nda208325/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda208325:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#fda-drugs-nda208325-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2017-02-07. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2018-28221</title><link>https://peptidescanner.com/stories/federal-register-2018-28221/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2018-28221:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#federal-register-2018-28221-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2018-12-28. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-27639083-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-27639083-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-27639083-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-12-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28063122-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28063122-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28063122-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Etelcalcetide for the treatment of secondary hyperparathyroidism.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28277829-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28277829-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28277829-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-12-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28508378-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28508378-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28508378-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-12-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28615947-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28615947-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28615947-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-03-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Parsabiv Could Be Pricey Addition In Care for CKD, ESRD Patients.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28661841-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28661841-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28661841-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-05-23. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathy…</title><link>https://peptidescanner.com/stories/pubmed-pmid-28867373-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28867373-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28867373-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-12-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Formulary Drug Review: Etelcalcetide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29276237-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29276237-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29276237-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29440923-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29440923-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29440923-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-03-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29691773-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29691773-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29691773-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-12. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29719376-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29719376-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29719376-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-11-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy].</title><link>https://peptidescanner.com/stories/pubmed-pmid-29786181-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29786181-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29786181-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-12-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Dramatic Regression of Parathyroid Gland Swelling After Conversion of Calcimimetic Medication From Cinacalcet to Etelcalcetide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29927050-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29927050-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29927050-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-12-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ?</title><link>https://peptidescanner.com/stories/pubmed-pmid-30009474-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30009474-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-30009474-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-12-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Etelcalcetide (Parsabiv) for Secondary Hyperparathyroidism in Adults With Chronic Kidney Disease on Hemodialysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30013296-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30013296-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-30013296-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-11-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology.</title><link>https://peptidescanner.com/stories/pubmed-pmid-31853791-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-31853791-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-31853791-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-06-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A Prospective, Randomized Clinical Trial of Etelcalcetide in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism (the DUET Trial).</title><link>https://peptidescanner.com/stories/pubmed-pmid-33305109-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-33305109-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-33305109-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-11-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-33825489-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-33825489-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-33825489-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-01-06. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride.</title><link>https://peptidescanner.com/stories/pubmed-pmid-34787825-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34787825-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-34787825-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-07-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation.</title><link>https://peptidescanner.com/stories/pubmed-pmid-36611532-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-36611532-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-36611532-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-03-08. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-36790677-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-36790677-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-36790677-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Acute and Severe Hypercalcemia Early After Kidney Transplantation in a Patient Previously Treated With Etelcalcetide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37383843-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37383843-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-37383843-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-03-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38050530-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38050530-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-38050530-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-12-06. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39081745-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39081745-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-39081745-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-05-18. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Real world evaluation of etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients in Argentina.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39557587-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39557587-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-39557587-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Measurement of ionized calcium with a point-of-care ionometer during etelcalcetide therapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41307414-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41307414-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-41307414-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Etelcalcetide Versus Cinacalcet for Secondary Hyperparathyroidism in Hemodialysis Patients: A Multicentre Comparison with 24 Months of Follow-Up.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42739661-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42739661-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-42739661-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Regression of uremic tumoral calcinosis following the switch from cinacalcet to etelcalcetide in a hemodialysis patient without severe hyperphosphatemia.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42853437-etelcalcetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42853437-etelcalcetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-42853437-etelcalcetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-12. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
